Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/amivantamab-linked-diverse-dermatologic-adverse-events-2026a10004zm?src=rss
Author :
Publish date : 2026-02-19 12:00:00
Copyright for syndicated content belongs to the linked Source.